Literature DB >> 12943747

Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.

Stephan Steckelbroeck1, Matthias Watzka, Annette Reissinger, Petra Wegener-Toper, Frank Bidlingmaier, Niklaas Bliesener, Volkmar H J Hans, Hans Clusmann, Michael Ludwig, Lothar Siekmann, Dietrich Klingmüller.   

Abstract

Estrogens play a crucial role in multiple functions of the brain and the proper balance of inactive estrone and active estradiol-17beta might be very important for their cerebral effects. The interconversion of estrone and estradiol-17beta in target tissues is known to be catalysed by a number of human 17beta-hydroxysteroid dehydrogenase (17beta-HSD) isoforms. The present study shows that enzyme catalysed interconversion of estrone and estradiol-17beta occurs in the human temporal lobe. The oxidative cerebral pathway preferred estradiol-17beta to Delta(5)-androstenediol and testosterone, whereas the reductive pathway preferred dehydroepiandrosterone (DHEA) to Delta(4)-androstenedione and estrone. An allosteric Hill kinetic for NAD-dependent oxidation of estradiol-17beta was observed, whereas a typical Michaelis-Menten kinetic was shown for NADPH-dependent reduction of estrone. Investigations of the interconversion of estrogens in cerebral neocortex (CX) and subcortical white matter (SC) preparations of brain tissue from 12 women and 10 men revealed no sex-differences, but provide striking evidence for the presence of at least one oxidative membrane-associated 17beta-HSD and one cytosolic enzyme that catalyses both the reductive and the oxidative pathway. Membrane-associated oxidation of estradiol-17beta was shown to be significantly higher in CX than in SC (P<0.05), whereas the cytosolic enzyme activities were significantly higher in SC than in CX (P<0.0005). Finally, real-time RT-PCR analyses revealed that besides 17beta-HSD types 4 and 5 also the isozymes type 7, 8, 10 and 11 show substantial expression in the human temporal lobe. The characteristics of the isozymes lead us to the conclusion that cytosolic 17beta-HSD type 5 is the best candidate for the observed cytosolic enzyme activities, whereas the data gave no clear answer to the question, which enzyme is responsible for the membrane-associated oxidation of estradiol-17beta. In conclusion, the study strongly suggests that different cell types and different isozymes are involved in the cerebral interconversion of estrogens, which might play a pivotal role in maintaining the functions of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943747     DOI: 10.1016/s0960-0760(03)00251-6

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  12 in total

1.  Non-stereo-selective cytosolic human brain tissue 3-ketosteroid reductase is refractory to inhibition by AKR1C inhibitors.

Authors:  Stephan Steckelbroeck; Dieter Lütjohann; David R Bauman; Michael Ludwig; Anke Friedl; Volkmar H J Hans; Trevor M Penning; Dietrich Klingmüller
Journal:  Biochim Biophys Acta       Date:  2010-07-29

2.  Human dehydrogenase/reductase (SDR family) member 8 (DHRS8): a description and evaluation of its biochemical properties.

Authors:  Tereza Lundová; Hana Štambergová; Lucie Zemanová; Markéta Svobodová; Jana Havránková; Miroslav Šafr; Vladimír Wsól
Journal:  Mol Cell Biochem       Date:  2015-10-16       Impact factor: 3.396

3.  Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants.

Authors:  Elahe A Mostaghel; Brett T Marck; Stephen R Plymate; Robert L Vessella; Stephen Balk; Alvin M Matsumoto; Peter S Nelson; R Bruce Montgomery
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

Review 4.  The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?

Authors:  M Bortolato; R Frau; S C Godar; L J Mosher; S Paba; F Marrosu; P Devoto
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

5.  Phylogenetic comparisons implicate sex hormone-binding globulin in "masculinization" of the female spotted hyena (Crocuta crocuta).

Authors:  Geoffrey L Hammond; Solange Miguel-Queralt; Tamer M Yalcinkaya; Caroline Underhill; Ned J Place; Stephen E Glickman; Christine M Drea; Aaron P Wagner; Pentti K Siiteri
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

6.  Molecular cloning and expression of 17β-hydroxysteroid dehydrogenase type 2 gene in Hu sheep.

Authors:  Chang Long Wang; Shi Jia Ying; Zi Yu Wang; Hui Jun Xing; Li Zhong Wang; Dong Yang He; Shen Hua Xiao; Feng Wang
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

Review 7.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 8.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

9.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

Authors:  R Bruce Montgomery; Elahe A Mostaghel; Robert Vessella; David L Hess; Thomas F Kalhorn; Celestia S Higano; Lawrence D True; Peter S Nelson
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Contribution of estrogen receptor subtypes, ERα, ERβ, and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice.

Authors:  Ashok Kumar; Linda A Bean; Asha Rani; Travis Jackson; Thomas C Foster
Journal:  Hippocampus       Date:  2015-06-12       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.